Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Physical Chemistry Chemical Physics : PCCP|August 6, 2016
Peptides@mica: from affinity to adhesion mechanismA Gladytz, T John, T Gladytz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersJohn M Timmerman, John C Byrd, David J Andorsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2010
HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk categoryAnn Woolfrey, Stephanie J Lee, Ted A Gooley, et al.
Cancers|August 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United StatesJoanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal, et al.
Nuclear Medicine Communications|September 8, 2012
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testesNaoya Hattori, Ajay K Gopal, Andrew T Shields, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
Blood|March 25, 2006
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomasJohn M Pagel, Yukang Lin, Nathan Hedin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrierE A Neuwelt, J A Barranger, R O Brady, et al.
Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.
Frontiers in Oncology|August 22, 2022
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndromeDominic LaBella, Samuel Regan, Heiko Konig, et al.
Pageof 22